Claude Sonnet 5 autonomously picks gene therapy and performs mouse brain surgery
A Claude Sonnet 5 model chose a gene therapy, brain region, and injection coordinates for surgery on a mouse model of epilepsy, then controlled the procedure using a motorized surgical rig. According to Gabriel Ocana-Santero of Exin Therapeutics, this marks the first time an AI agent has both selected a treatment and delivered it to a living mammal without human intervention. The agent analyzed…
Key points
- Claude Sonnet 5 autonomously chose drug, brain region, and injection coordinates for epilepsy surgery on a mouse
- Agent halted procedure mid-surgery after detecting a calibration error, refusing to bypass safety limits
- More capable Claude Opus models declined to perform the live procedure due to alignment concerns
Model page: Claude Opus 5.5 →
A Claude model autonomously chose a gene therapy and operated on a mouse brain with no human decision-making
The Decoder · 30 October 2026
Loading the full article…
This text was published by The Decoder and written by Matthias Bastian. It is reproduced here with attribution so you can read it in full; the rights remain with the publisher. Read it at the source ↗
The headline, key points and digest above were generated by Digest AI's editorial model from the linked sources. Automated summaries can contain errors: the sources are the record. Spotted a mistake? Tell us. Published by Martin K., who runs Digest AI and handles corrections.
More in Robotics & Physical AI
All →- Percepto unveils Axion AI platform for cross-drone inspection data analysis · 1 src
- RAI robot demonstrates whole-body manipulation in complex tasks · 1 src
- Agility Robotics plans $465M capital raise ahead of SPAC deal · 2 src
- Empiric Earth’s Jen Vescio leads physical AI’s real-world data push · 1 src
- Schneider, NVIDIA and HPE launch AI agents for process plants · 1 src
Comments
via GitHub Discussions